SCHEMBL29316554

SCHEMBL29316554

CCCCCCCCC(O)c1cccc(C(=O)OC)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.46
PPARG P37231 2/20 0.42
PPARA Q07869 1/20 0.42
CYP1A2 P05177 3/20 0.42
CES1 P23141 1/20 0.40
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
RECQL P46063 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GRM5 P41594 1/20 0.39
KDM4E B2RXH2 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRSS1 P07477 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22633335 0.83 MAPT (0.42) FAAHCYP1A2CES1MAPTGAA
SCHEMBL22235165 0.81 MAPT (0.44) FAAHCYP1A2CES1MAPTGAA
SCHEMBL24418340 0.81 MEN1 (0.46) FAAHMAPTGAACYP3A4KMT2A
SCHEMBL29672768 0.81 MEN1 (0.46) FAAHMAPTGAACYP3A4KMT2A
SCHEMBL18879240 0.79 CYP1A2 (0.45) CYP1A2CES1MAPTGAARECQL
SCHEMBL29316578 0.78 CYP1A2 (0.39) FAAHCYP1A2CES1MAPTGAA
SCHEMBL18511690 0.77 CYP1A2 (0.47) FAAHCYP1A2MAPTGAARECQL
SCHEMBL16834536 0.76 MAPT (0.48) CYP1A2MAPTGAARECQLNPC1
SCHEMBL29316553 0.76 MAPT (0.49) FAAHCYP1A2CES1MAPTGAA
SCHEMBL18672435 0.76 CYP1A2 (0.47) CYP1A2MAPTGAARECQLNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238461-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF JANSSEN BIOTECH, INC. 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238461-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF BDNF, CD47, MAG FAAH 2845/4885PPARG 1551/4885PPARA 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.